Clinical Trial

Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder

Study acronym: ADOLIMIS
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study aims to better understand the behavioral, neurobiological and hormonal underpinnings of stress and reward reactivity of adolescents suffering from borderline personality disorder compared to healthy adolescents by a multimodal approach based on clinical assessments, structural and functional mri and experimental acute stress exposure.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2017-07-03; most recent amendment 2025-03-11.
Status change: Not Yet Recruiting → Active, Not Recruiting 2021-08-25
Trial Details
NCT Number NCT03209102
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Conditions Borderline Personality Disorder, Adolescent Development
Enrollment 66 participants
Start Date 2017-10-04
Primary Completion 2024-10-04 (estimated)
Study Completion 2026-01-03 (estimated)
Updated on ClinicalTrials.gov 2025-03-13